To sum up, licochalcone B may also become a herbal monomer against COVID‐19, and it is hypothesized that it may inhibit the signaling flux of IL‐17, VEGF, prolactin, and C‐type lectin receptor pathway, by acting on multiple target proteins, thus achieving the effect against COVID‐19. The gene discussed is PRL; the disease is COVID-19.